Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06294587
Other study ID # IRB-300012407
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 2024
Est. completion date July 2027

Study information

Verified date May 2024
Source University of Alabama at Birmingham
Contact Hussein Basma, DDS, MS
Phone 205-975-2888
Email basma86@uab.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical trial aims to compare and evaluate the clinical outcomes between two distinct treatment sequences: free gingival graft surgery preceding guided bone regeneration and guided bone regeneration followed by free gingival graft.


Description:

This clinical trial aims to compare and evaluate the clinical outcomes between two distinct treatment sequences: free gingival graft surgery preceding guided bone regeneration and guided bone regeneration followed by free gingival graft. The primary objective is to assess the influence of the tissue graft timing on the outcomes of the guided bone regeneration. The secondary goal is to compare the complications that may arise following the two procedures before implant placement.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date July 2027
Est. primary completion date July 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - • At least 18 years old - No uncontrolled medical conditions or medications that will affect their bone healing. - Good oral hygiene is defined as a full-mouth plaque score =25%11. - Must be able to read and understand the informed consent document. - Has a need for implants to replace missing tooth/teeth in at least 1 quadrant of the mouth. - Insufficient alveolar ridge width for endosseous implant placement, defined as 5 mm or less, as determined by bone sounding and CBCT scan. - The patient and/or guardian is willing and able to comply with pre-operative and post-operative diagnostic and clinical evaluations required. - The patient is not pregnant or breastfeeding. Exclusion Criteria: - Active infectious diseases. - Liver or kidney dysfunction/failure. - Uncontrolled diabetes (HbA1c = 8.5). - Active cancer treatment - such as active chemotherapy radiation therapy, or radiotherapy performed within =12 months from the procedure. - Taking medications that will affect their bone healing (for example, bisphosphonates and long-term anti-inflammatory medications). - Metabolic bone diseases that affect bone healing such as osteoporosis. - Pregnant or lactating women (self-reported). - Current tobacco and Marijuana smokers have 10 or more cigarettes per day, and former smokers (> 10 cigarettes) who quit < 10 ago (self-reported). - Poor oral hygiene. - Vertical loss of bone at the edentulous ridge. - History of periodontal disease. - The patient is pregnant or breastfeeding

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
FGG Before GBR
Free Gingival Graft before the guided bone regeneration,
FGG after GBR
Free Gingival Graft after the guided bone regeneration,

Locations

Country Name City State
United States Unversity of Alabama at Birmingham, School of Dentistry Birmingham Alabama

Sponsors (1)

Lead Sponsor Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Volumetric outcome assessment The volumetric outcomes of interest will be volume change in mm3 (Vol) and the mean distance between the surface/mean thickness of the reconstructed volume in mm. Baseline to 12 months
Primary Buccal soft tissue profile The assessment involves measuring the profile of the buccal soft tissue from the implant shoulder. Baseline to 12 months